Main Title |
Development document for effluent guidelines, new source performance standards and pretreatment standards for the pharmaceutical manufacturing point source category / |
Other Authors |
|
CORP Author |
Environmental Protection Agency, Washington, DC. Effluent Guidelines Div. |
Publisher |
Effluent Guidelines Division, Office of Water, U.S. Environmental Protection Agency, |
Year Published |
1982 |
Report Number |
EPA 440-1-82-084 |
Stock Number |
PB94-120110 |
OCLC Number |
10806908 |
Subjects |
Pharmaceutical industry--Evaluation ;
Drug industry ;
Industrial waste treatment ;
Chemical effluents ;
Pollution regulations ;
Water pollution control ;
Water pollution abatement ;
Waste water ;
Point sources ;
Industrial plants ;
Water pollution sampling ;
Water pollution economics ;
Economic impact ;
Pretreatment ;
Treatment technology ;
BAT(Best available technology)
|
Additional Subjects |
Drug industry ;
Industrial waste treatment ;
Chemical effluents ;
Pollution regulations ;
Water pollution control ;
Water pollution abatement ;
Waste water ;
Point sources ;
Industrial plants ;
Water pollution sampling ;
Water pollution economics ;
Economic impact ;
Pretreatment ;
Treatment technology ;
BAT(Best available technology)
|
Internet Access |
|
Holdings |
Library |
Call Number |
Additional Info |
Location |
Last Modified |
Checkout Status |
EHAD |
EPA/440-1-82-084 |
|
Region 1 Library/Boston,MA |
04/09/1999 |
ERAD |
EPA 440/1-82-084b |
|
Region 9 Library/San Francisco,CA |
03/25/2016 |
NTIS |
PB94-120110 |
Some EPA libraries have a fiche copy filed under the call number shown. |
|
07/26/2022 |
|
Collation |
1 volume (various pagings) : charts ; 28 cm |
Abstract |
The document presents the technical data to support effluent limitations for the pharmaceutical manufacturing point source category as required by the Clean Water Act (The Act) and related settlement agreements. It also presents the technologies to achieve limitations as defined by an amended best practicable control technology currently available (BPT), best available technology economically achievable (BAT) and best conventional pollutant control technology (BCT), and standards as defined by new source performance standards (NSPS), and pretreatment standards for new and existing sources (PSNS and PSES). The pharmaceutical manufacturing point source category manufacture biological products, medicinal chemicals, botanical products and pharmaceutical products. |
Notes |
"November 1982." "EPA 400/1-82/084." |